Vishal Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.69 M
- Company Age 31 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.90 Cr
- Revenue Growth 77.75%
- Profit Growth 185.89%
- Ebitda 107.74%
- Net Worth 30.54%
- Total Assets 34.97%
About Vishal Laboratories
Vishal Laboratories Private Limited (VLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 01 April 1993 and has a history of 31 years and ten months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.69 M.
The company has closed loans amounting to ₹1.90 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ranjan Mhatre and Shirley Mhatre serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230MH1993PTC071441
-
Company No.
071441
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Apr 1993
-
Date of AGM
30 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Vishal Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ranjan Mhatre
|
Director | 01-Apr-1993 | Current |
|
Shirley Mhatre
|
Director | 30-Sep-2002 | Current |
Financial Performance of Vishal Laboratories.
Vishal Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 77.75% increase. The company also saw a substantial improvement in profitability, with a 185.89% increase in profit. The company's net worth Soared by an impressive increase of 30.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vishal Laboratories?
In 2019, Vishal Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹19.00 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 1.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Feb 2008 | State Bank Of India | ₹1.10 Cr | Satisfied |
| 16 Feb 2008 | State Bank Of India | ₹5.00 M | Satisfied |
| 27 Aug 1994 | State Bank Of India | ₹3.00 M | Satisfied |
How Many Employees Work at Vishal Laboratories?
Vishal Laboratories has a workforce of 11 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vishal Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vishal Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
